CAMP Q4 2023 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$13M

Net Income

-$13M

EPS (Diluted)

$-2.27

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$636,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$179M

Stockholders' Equity

-$124M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$79M	-100.0%
Gross Profit	$0	$27M	-100.0%
Operating Income	-$13M	-$4M	-270.7%
Net Income	-$13M	-$5M	-174.5%

Revenue Segments

Product

$31M58%

Application Subscriptions And Other Services

$22M42%

Geographic Segments

UNITED STATES

$29M54%

EMEA

$14M27%

Asia Pacific

$5M9%

Latin America

$4M7%

All Other

$2M3%